Developmental and oncogenic signalling
2021 SGR 01609
![Foto de Developmental and oncogenic signalling](/img/grupo.png)
![Foto de Institut d'Investigació Biomédica de Bellvitge](/img/noimage_org.png)
Institut d'Investigació Biomédica de Bellvitge
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institut d'Investigació Biomédica de Bellvitge (7)
2024
-
Sprouty1 is a broad mediator of cellular senescence
Cell Death and Disease, Vol. 15, Núm. 4
2023
-
Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness
Molecular Oncology, Vol. 17, Núm. 1, pp. 98-118
2022
2016
-
Cytoplasmic cyclin D1 regulates cell invasion and metastasis through the phosphorylation of paxillin
Nature Communications, Vol. 7
2015
-
Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer
International Journal of Cancer, Vol. 136, Núm. 8, pp. 1863-1873
2007
-
Apoptotic action of E2F1 requires glycogen synthase kinase 3-β activity in PC12 cells
Journal of Neurochemistry, Vol. 102, Núm. 6, pp. 2020-2028
2006
-
Arginine transport via cationic amino acid transporter 2 plays a critical regulatory role in classical or alternative activation of macrophages
Journal of Immunology, Vol. 176, Núm. 10, pp. 5918-5924